|
Re: Music to your ears....Dr. Sledge's prediction on her2+ breast cancer
I suspect this is just a badly framed announcement. I'm sure Dr Sledge is as eager for long term survival for HER2 breast cancer patients as we are. He's thinking about the natural history of the disease and the way in the past it took people rapidly and used the 3 year figure (because that's from a recent study and longer term data on Perjeta etc isn't out yet). I think it was a rah-rah "isn't it great what's been achieved, let's keep going" message to inspire the symposium delegates, rather than a "that's good enough - move on to other diseases now" message.
Aussie Girl
__________________
31mm Infiltrating duct carcinoma
Grade 3, ER/PR-, HER2+, Neg Sentinel nodes x 5
49mm field of DCIS
17 June '13: Screen detected impalpable mass, Mammogram neg, US.
25 June '13: Diagnosed after multiple biopsies and MRIs
28 June '13: Left lumpectomey
4 July '13: Left Mastectomy
12 August '13: Commenced TCH chemo
Mid December '13 : TCH finished. Herceptin continuing three weekly.
4 August 2014- Herceptin infusions finished.
END OF THERAPY - YAY!
|